GP-Act III Acquisition (GPAT) Stock Price, News & Analysis

Company Overview

GP-Act III Acquisition Corp. is a Cayman Islands exempted company formed in 2021 as a special purpose acquisition company (SPAC) focused on completing a business combination with one or more companies in sectors such as technology, healthcare and consumer goods.

Through its publicly traded shares on the Nasdaq under the ticker GPAT, the company seeks to leverage its sponsor group’s experience in private equity and capital markets to identify and partner with growth-oriented businesses. The SPAC structure enables it to pursue assets that can benefit from operational support and access to public markets.

While GP-Act III Acquisition Corp. has not yet announced a definitive merger agreement or acquisition target, it continues to evaluate opportunities across North America, Europe and Asia. The company’s management team brings backgrounds in investment banking, corporate development and finance, positioning it to assess potential partners with scalability and strong growth potential.

Upon completion of a qualifying business combination, GP-Act III Acquisition Corp. intends to provide its selected target with access to public capital markets and strategic guidance, aiming to foster long-term value creation for shareholders and support the combined company’s future growth initiatives.

Key Stats

• Today's Range: $10.60 to $10.60
• 50-Day Range: $10.53 to $10.60
• 52-Week Range: $10.00 to $10.64
• Volume: 118 shs
• Average Volume: 107,750 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GPAT Stock Analysis - Frequently Asked Questions

How have GPAT shares performed this year?

GP-Act III Acquisition's stock was trading at $10.14 at the start of the year. Since then, GPAT stock has increased by 4.4% and is now trading at $10.5850.

Who are GP-Act III Acquisition's major shareholders?

Top institutional shareholders of GP-Act III Acquisition include Karpus Management Inc., Meteora Capital LLC, Alberta Investment Management Corp and AQR Arbitrage LLC.

How do I buy shares of GP-Act III Acquisition?

Shares of GPAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of GP-Act III Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that GP-Act III Acquisition investors own include Andretti Acquisition Corp. II (POLEU), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR), Aimfinity Investment Corp. I (AIMAU) and Aimei Health Technology (AFJK).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:GPAT
• CIK: 1834526
• Web: N/A
• Phone: (212) 430-4340
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A